Marc Wagner’s knowledge of pharmaceutical compliance adds value to his developing practice. He has experience interpreting FDA guidance documents, prescription drug monitoring programs, Investigational New Drug Application requirements, and state board of pharmacy rules and regulations. Additionally, Marc’s educational and professional background in pharmacy provides him with a substantial understanding of a variety of pharmaceutical compliance measures, including pharmaceutical compounding, 503B outsourcing facilities, pharmacy reimbursement, FDA labeling requirements, and Drug Enforcement Administration requirements. This background enables Marc to assist with due diligence in life science transactions and navigate federal and state licensing for drug manufacturers, wholesale distributors, pharmacies, and outsourcing facilities.